Literature DB >> 16624864

Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.

Christiane Stuhlmann-Laeisz1, Sigrid Lang, Athena Chalaris, Paliga Krzysztof, Sudarman Enge, Jutta Eichler, Ursula Klingmüller, Michael Samuel, Matthias Ernst, Stefan Rose-John, Jürgen Scheller.   

Abstract

The mode of activation of glycoprotein 130 kDa (gp130) and the transmission of the activation status through the plasma membrane are incompletely understood. In particular, the molecular function of the three juxtamembrane fibronectin III-like domains of gp130 in signal transmission remains unclear. To ask whether forced dimerization of gp130 is sufficient for receptor activation, we replaced the entire extracellular portion of gp130 with the c-jun leucine zipper region in the chimeric receptor protein L-gp130. On expression in cells, L-gp130 stimulates ligand-independent signal transducer and activator of transcription (STAT) 3 and extracellular signal-regulated kinase 1/2 phosphorylation. gp130 activation could be abrogated by the addition of a competing peptide comprising the leucine zipper region of c-fos. When stably expressed in the interleukin-3-dependent Ba/F3 murine pre-B-cells, these cells showed constitutive STAT3 activation and cytokine-independent growth over several months. Because gp130 stimulation completely suppressed differentiation of murine embryonic stem cells in vitro, we also stably expressed L-gp130 in these cells, which completely blocked their differentiation in the absence of cytokine stimulation and was consistent with high constitutive expression levels of the stem cell factor OCT-4. Thus, L-gp130 can be used in vitro and in vivo to mimic constitutive and ligand-independent activation of gp130 and STAT3, the latter of which is frequently observed in neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624864      PMCID: PMC1483035          DOI: 10.1091/mbc.e05-12-1129

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  56 in total

1.  Functional replacement of cytokine receptor extracellular domains by leucine zippers.

Authors:  N Patel; J M Herrman; J C Timans; R A Kastelein
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

2.  I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.

Authors:  M Fischer; J Goldschmitt; C Peschel; J P Brakenhoff; K J Kallen; A Wollmer; J Grötzinger; S Rose-John
Journal:  Nat Biotechnol       Date:  1997-02       Impact factor: 54.908

3.  Signaling of type II oncostatin M receptor.

Authors:  P Auguste; C Guillet; M Fourcin; C Olivier; J Veziers; A Pouplard-Barthelaix; H Gascan
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

4.  Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.

Authors:  U Horsten; G Müller-Newen; C Gerhartz; A Wollmer; J Wijdenes; P C Heinrich; J Grötzinger
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

Review 5.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

Review 6.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  Erythropoietin receptor activation by a ligand-induced conformation change.

Authors:  I Remy; I A Wilson; S W Michnick
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

8.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation.

Authors:  O Livnah; E A Stura; S A Middleton; D L Johnson; L K Jolliffe; I A Wilson
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

Review 9.  IL-6 cytokine family and signal transduction: a model of the cytokine system.

Authors:  M Hibi; K Nakajima; T Hirano
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

10.  Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction.

Authors:  R Starr; U Novak; T A Willson; M Inglese; V Murphy; W S Alexander; D Metcalf; N A Nicola; D J Hilton; M Ernst
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

View more
  29 in total

Review 1.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

2.  Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation.

Authors:  Thorben M Hummel; Theresa Ackfeld; Marco Schönberg; Gregor Ciupka; Falk Schulz; Anne Oberdoerster; Joachim Grötzinger; Jürgen Scheller; Doreen M Floss
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

3.  GP130 activation induces myeloma and collaborates with MYC.

Authors:  Tobias Dechow; Sabine Steidle; Katharina S Götze; Martina Rudelius; Kerstin Behnke; Konstanze Pechloff; Susanne Kratzat; Lars Bullinger; Falko Fend; Valeria Soberon; Nadya Mitova; Zhoulei Li; Markus Thaler; Jan Bauer; Elke Pietschmann; Corinna Albers; Rebekka Grundler; Marc Schmidt-Supprian; Jürgen Ruland; Christian Peschel; Justus Duyster; Stefan Rose-John; Florian Bassermann; Ulrich Keller
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

4.  Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.

Authors:  Anna K Scherger; Mona Al-Maarri; H. Carlo Maurer; Markus Schick; Sabine Maurer; Rupert Öllinger; Irene Gonzalez-Menendez; Manuela Martella; Markus Thaler; Konstanze Pechloff; Katja Steiger; Sandrine Sander; Jürgen Ruland; Roland Rad; Leticia Quintanilla-Martinez; Frank T Wunderlich; Stefan Rose-John; Ulrich Keller
Journal:  JCI Insight       Date:  2019-08-08

5.  Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling.

Authors:  Jan Sommer; Timo Effenberger; Elena Volpi; Georg H Waetzig; Marten Bernhardt; Jan Suthaus; Christoph Garbers; Stefan Rose-John; Doreen M Floss; Jürgen Scheller
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

6.  Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo.

Authors:  Dana M Bronte-Tinkew; Mauricio Terebiznik; Aime Franco; Michelle Ang; Diane Ahn; Hitomi Mimuro; Chihiro Sasakawa; Mark J Ropeleski; Richard M Peek; Nicola L Jones
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Forced homo- and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth.

Authors:  Jan Suthaus; Anna Tillmann; Inken Lorenzen; Elena Bulanova; Stefan Rose-John; Jürgen Scheller
Journal:  Mol Biol Cell       Date:  2010-06-16       Impact factor: 4.138

8.  Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.

Authors:  Nina Adam; Björn Rabe; Jan Suthaus; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

9.  Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.

Authors:  Marine Lacroix; François Rousseau; Florence Guilhot; Pauline Malinge; Giovanni Magistrelli; Suzanne Herren; Simon A Jones; Gareth W Jones; Jürgen Scheller; Rami Lissilaa; Marie Kosco-Vilbois; Zoë Johnson; Vanessa Buatois; Walter Ferlin
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

10.  The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells.

Authors:  Saeideh Nakhaei-Rad; Hossein Nakhaeizadeh; Silke Götze; Claus Kordes; Iris Sawitza; Michèle J Hoffmann; Manuel Franke; Wolfgang A Schulz; Jürgen Scheller; Roland P Piekorz; Dieter Häussinger; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2016-02-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.